White House Press Secretary Karoline Leavitt misspelled Cincinnati in a post on X about Trump's visit to a biotechnology company in Reading.

The Company’s presence at ATTD follows compelling clinical performance data from its latest CGM technology developments, which formed the basis for Trinity Biotech’s decision to advance the program ...

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap ...

Platform Rebrand of Researgency.ai; First Purpose-Built AI Agent for Biotech Expected to Ship Within Two WeeksARLINGTON, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) ...

The company is pursuing a Phase 3 trial in its most exciting pipeline drug, and investors are awaiting potentially exciting ...

President Donald Trump has often mentioned his experience at Swifton Village when he comes into. He doesn't mention what went wrong there.

“Strategic transformations are a common and often successful approach in biotechnology,” Rami Levin, who took over as CEO of ...

UCB’s licensing deal with China’s Antengene follows rising global demand for Chinese-developed drug candidates ...

This biotech specializes in antibody therapies for autoimmune diseases, with its lead candidate progressing through trials.

A new biotech company forged through an Australian and Danish partnership will accelerate treatments for children and adults ...

Dr.Thomas L. F. Montgomery Andresen joins from T-Cypher BioFollows breakthrough non-human primate data demonstrating deep B-cell depletion without cytokine releaseCommit is poised to nominate its ...